AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)

 AIDS, Uncategorized  Comments Off on CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)
May 282013
 

Links

http://newdrugapprovals.wordpress.com/2013/05/28/cfda-approves-clinical-trials-for-novel-china-aids-treatment-azi-fu-azvudine/

Share

China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device

 china, Uncategorized  Comments Off on China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device
May 272013
 

 

Links

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/chinas-curative-medical-to-seek-cfda-approval-for-alungs-respiratory-device/

Share

AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan

 Uncategorized  Comments Off on AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan
May 272013
 

Links

 

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/abbvie-and-eisai-announce-humira-pre-filled-syringe-has-received-approval-for-the-treatment-of-intestinal-behcets-disease-in-japan/

Share

RESVERATROL AND ITS BENEFITS

 Uncategorized  Comments Off on RESVERATROL AND ITS BENEFITS
May 272013
 

SEE MY PRESENTATION

Links

 

http://newdrugapprovals.wordpress.com/2013/05/27/resveratrol-and-its-benefits-my-presentation-on-slideshare/

OR

http://www.slideshare.net/anthonycrasto64/anthony-crasto-resveratrol-synthesis-and-benefits

Share

Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine

 Phase 3 drug, Uncategorized  Comments Off on Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine
May 262013
 

PREDADENANT

 

Links

http://newdrugapprovals.wordpress.com/2013/05/26/merck-provides-update-on-phase-iii-clinical-program-for-preladenant-the-companys-investigational-parkinsons-disease-medicine/

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: